昆明医科大学学报
昆明醫科大學學報
곤명의과대학학보
Journal of Kunming Medical University
2013年
11期
62-65
,共4页
李悦%何睿哲%蒋东%王颖昭
李悅%何睿哲%蔣東%王穎昭
리열%하예철%장동%왕영소
抑郁症%催眠疗法%症状自评量表
抑鬱癥%催眠療法%癥狀自評量錶
억욱증%최면요법%증상자평량표
Depression%Hypnotherapy%Symptom checklist
目的:探讨催眠疗法对抑郁症患者及其家庭的影响.方法选择136例住院或门诊治疗的抑郁症患者,按照入组顺序分为研究组和对照组.研究组采用催眠疗法,对照组采用常规抗抑郁药文拉法辛.对2组患者观察6周,第0、6周时作汉密尔顿焦虑量表(HAMA)、汉密尔顿抑郁量表(HAMD),对其家人作症状自评量表(SCL-90)、家庭功能评定量表(FAD)评分.结果2组间临床疗效差异无统计学意义(>0.05);治疗前后,2组间比较HAMD、HAMA评分差异均无统计学意义(>0.05),组内比较,两组HAMD、HAMA评分差异均有统计学意义(<0.05);2组家庭成员SCL-90各因子分差异均无统计学意义(>0.05);2组间比较,第0、6周FAD各因子分差异均无统计学意义(>0.05),组内比较,情感介入、沟通和总分差异均有统计学意义(<0.05);HAMA因子分与家庭总功能成正相关关系(<0.05);HAMD因子分与情感介入成正相关关系(<0.05).结论催眠疗法与抗抑郁药疗效相当,可以有效改善患者的抑郁、焦虑情绪及其家庭功能.
目的:探討催眠療法對抑鬱癥患者及其傢庭的影響.方法選擇136例住院或門診治療的抑鬱癥患者,按照入組順序分為研究組和對照組.研究組採用催眠療法,對照組採用常規抗抑鬱藥文拉法辛.對2組患者觀察6週,第0、6週時作漢密爾頓焦慮量錶(HAMA)、漢密爾頓抑鬱量錶(HAMD),對其傢人作癥狀自評量錶(SCL-90)、傢庭功能評定量錶(FAD)評分.結果2組間臨床療效差異無統計學意義(>0.05);治療前後,2組間比較HAMD、HAMA評分差異均無統計學意義(>0.05),組內比較,兩組HAMD、HAMA評分差異均有統計學意義(<0.05);2組傢庭成員SCL-90各因子分差異均無統計學意義(>0.05);2組間比較,第0、6週FAD各因子分差異均無統計學意義(>0.05),組內比較,情感介入、溝通和總分差異均有統計學意義(<0.05);HAMA因子分與傢庭總功能成正相關關繫(<0.05);HAMD因子分與情感介入成正相關關繫(<0.05).結論催眠療法與抗抑鬱藥療效相噹,可以有效改善患者的抑鬱、焦慮情緒及其傢庭功能.
목적:탐토최면요법대억욱증환자급기가정적영향.방법선택136례주원혹문진치료적억욱증환자,안조입조순서분위연구조화대조조.연구조채용최면요법,대조조채용상규항억욱약문랍법신.대2조환자관찰6주,제0、6주시작한밀이돈초필량표(HAMA)、한밀이돈억욱량표(HAMD),대기가인작증상자평량표(SCL-90)、가정공능평정량표(FAD)평분.결과2조간림상료효차이무통계학의의(>0.05);치료전후,2조간비교HAMD、HAMA평분차이균무통계학의의(>0.05),조내비교,량조HAMD、HAMA평분차이균유통계학의의(<0.05);2조가정성원SCL-90각인자분차이균무통계학의의(>0.05);2조간비교,제0、6주FAD각인자분차이균무통계학의의(>0.05),조내비교,정감개입、구통화총분차이균유통계학의의(<0.05);HAMA인자분여가정총공능성정상관관계(<0.05);HAMD인자분여정감개입성정상관관계(<0.05).결론최면요법여항억욱약료효상당,가이유효개선환자적억욱、초필정서급기가정공능.
Objective To investigate the influence of hypnotherapy in patients with depression and their families. Methods One hundred and thirty-six cases of hospitalization or outpatient patients with depression were divided into the study group and the control group according to the order. The study group and the control group were treated with hypnosis therapy and venlafaxine, respectively. All patients were observed for 6 weeks. Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD) were assessed for patients with depression and the Symptom Checklist (SCL-90) and family assessment table (FAD) were assessed for thir families in the 0 and 6 weeks. Results There were no significant differences between the two groups in the clinical efficacy (χ2=1.31,> 0.05) and the HAMD, HAMA scores in the 0 and 6 weeks ( >0.05) . There were significant differences between the 0 and 6 weeks within the two groups in the HAMD and HAMA scores ( < 0.05). There was no significant difference between the family members of two groups in the SCL-90 factor scores in the 0 and 6 weeks (>0.05) . There was no significant difference between the two groups in the FAD factor scores in the 0 and 6 weeks. There was significant difference between the 0 and 6 weeks within the two groups with emotional involvement, communication and FAD total scores ( <0.05). There were positiue correlations between the HAMA factor scores and FAD total scores ( <0.05) and between the HAMD factor scores and emotional involvement scores ( <0.05) . Conclusion There was equivalent efficacy between hypnotherapy and antidepressants in patients with depression. Hypnotherapy can effectively make the patient's depression and anxiety better and improve their family functions.